Abstracts tagged "EHR best practices"

Abstract Number: 1225 • 2016 ACR/ARHP Annual Meeting
Serum Uric Acid Testing Practices over Five Years Among Incident Gout Cases
Dena H. Jaffe¹, Arriel Benis², Natalia M. Flores³, Hagit Gabay², Robert Morlock⁴, Alyssa Klein⁵, Dana Y Teltsch⁶, Jonathan Chapnick⁷, Becca Feldman², Yair Molad⁸, Shmuel M Giveon⁹ and Maya Leventer-Roberts², ¹Health Outcomes Research, Kantar Health, Jerusalem, Israel, ²Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel, ³Kantar Health, Foster City, CA, ⁴4939 Directors Place, Ardea Biosciences, Inc., San Diego, CA, ⁵AstraZeneca, Gaithersburg, MD, ⁶Evidera, Lexington, MA, ⁷Kantar Health, Horsham, PA, ⁸Rheumatology, Rabin Medical Center, Beilinson, Petah Tikva, Israel, ⁹Clalit Health Services, Tel Aviv, Israel
Background/Purpose: Gout is a chronic inflammatory disorder associated with elevated levels of serum uric acid (sUA), resulting in urate crystal deposits in soft tissues. Uncontrolled…
Abstract Number: 1830 • 2014 ACR/ARHP Annual Meeting
A Novel Population Care Model in Rheumatoid Arthritis – Significant Improvement in Quality and Reduction in Cost of Care
Eric D. Newman¹, William T. Ayoub², David M. Pugliese³, Chelsea Cedeno⁴, Jason Brown⁵, Thomas M. Harrington⁶, Thomas P. Olenginski⁶, Androniki Bili⁷, Alfred E. Denio⁶, Lisa L. Schroeder⁷, Dennis Torretti⁷, Tarun Sharma⁷, Lyudmila Kirillova⁷, Susan Mathew⁷, Jonida Cote⁷, Brian Oppermann², Cynthia Sullivan², Shantanu Bishwal⁸, Brian DelVecchio³ and Howard Aylward⁹, ¹Department of Rheumatology, Geisinger Health System, Danville, PA, ²Rheumatology, Geisinger Health System, State College, PA, ³Rheumatology, Geisinger Health System, Wilkes-Barre, PA, ⁴Division of Medicine, Geisinger Medical Center, Geisinger Health System, Danville, PA, ⁵Henry Hood Center for Clinical Research, Geisinger Health System, Danville, PA, ⁶Dept of Rheumatology, Geisinger Health System, Danville, PA, ⁷Rheumatology, Geisinger Health System, Danville, PA, ⁸Rheumatology, Geisinger Health System, Wilkes Barre, PA, ⁹Geisinger Health System, State College, PA
Background/Purpose: Rheumatoid arthritis (RA) is a common chronic disease with significant morbidity, mortality, and cost. To optimize care for RA patients, we developed a novel…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].